-
Product Insights
Optic Nerve Injury - Drugs In Development, 2024
Empower your strategies with our Optic Nerve Injury – Drugs In Development, 2024 report and make more profitable business decisions. Optic Nerve Injury or optic neuropathy is a common cause of vision loss occurring as a result of damage to the optic nerve. Optic nerve is a group or bundle of nerve fibers that carry out the communication between the eyes and brain. Trauma can be a common cause or complicated cases of diabetic retinopathy can also cause ONI. Neuroimaging studies...
-
Product Insights
Anterior Uveitis - Drugs In Development, 2024
Empower your strategies with our Anterior Uveitis – Drugs In Development, 2024 report and make more profitable business decisions. Inflammation of the eyes is known as Uveitis. If inflammation occurs at the anterior portion of the eye (iris) it is known as anterior uveitis. Uveitis damages the uvea, the middle layer of the eye consisting of the iris, ciliary body, and choroid. Common causes are any trauma to the eye, underlying health issues like diabetes, viral infections HSV, syphilis, TB, and...
-
Product Insights
Herpetic Keratitis - Drugs In Development, 2024
Empower your strategies with our Herpetic Keratitis – Drugs In Development, 2024 report and make more profitable business decisions. Herpetic Keratitis is an inflammation or infection of cornea of the eye caused by HSV (herpes simplex virus). It is a viral infection and is classified as type-1 and type-2. Spread of HSV to the eyes causes herpetic keratitis. Presence of HSV infection and other triggering factors like exposure to direct sunlight, drug-induced, stress. Herpetic keratitis is further classified as epithelial keratitis,...
-
Product Insights
Intermediate Uveitis - Drugs In Development, 2024
Empower your strategies with our Intermediate Uveitis – Drugs In Development, 2024 report and make more profitable business decisions. Intermediate uveitis is a type of uveitis, which is an inflammation of the uvea, the middle layer of the eye. Intermediate uveitis specifically involves inflammation in the vitreous, a gel-like substance in the middle of the eye and lead to the formation of inflammatory cells and debris in the vitreous. Symptoms include floaters, blurred vision, eye pain and redness. Diagnosis includes comprehensive...
-
Product Insights
Viral Conjunctivitis - Drugs In Development, 2024
Empower your strategies with our Viral Conjunctivitis – Drugs In Development, 2024 report and make more profitable business decisions. Viral conjunctivitis, or pinkeye, is a common, self-limiting condition that is typically caused by adenovirus. Viral conjunctivitis is highly contagious, usually for 10–12 days from onset as long as the eyes are red. Symptoms include itchy eyes, tearing, redness, discharge, and light sensitivity (with corneal involvement). Treatment includes lubricants, vasoconstrictors, and antihistamines. The Viral Conjunctivitis drugs in development market research report provide...
-
Product Insights
Persistent Corneal Epithelial Defects - Drugs In Development, 2024
Empower your strategies with our Persistent Corneal Epithelial Defects – Drugs In Development, 2024 report and make more profitable business decisions. Persistent corneal epithelial defects result from failure of re-epithelialization and complete healing within two weeks of corneal epithelial insult, even after conventional treatment. Persistent epithelial defects necessitate prompt and vigilant treatment to avoid associated potential complications, such as infection, vision loss, corneal scarring, melting, and even perforation The Persistent Corneal Epithelial Defects drugs in development market research report provide comprehensive...
-
Product Insights
Proliferative Vitreoretinopathy (PVR) - Drugs In Development, 2024
Empower your strategies with our Proliferative Vitreoretinopathy (PVR) – Drugs In Development, 2024 report and make more profitable business decisions. Proliferative vitreoretinopathy (PVR) occurs when a scar forms under or on the retina after retinal detachment, preventing the retina from healing and falling back into place. Risk factors for proliferative vitreoretinopathy include bleeding within the eye, increased inflammation from trauma, high degree myopia (short-sightedness), family history, severe inflammation, or complications from diabetes. The Proliferative Vitreoretinopathy (PVR) drugs in development market research...
-
Product Insights
Bacterial Conjunctivitis - Drugs In Development, 2024
Empower your strategies with our Bacterial Conjunctivitis – Drugs In Development, 2024 report and make more profitable business decisions. Bacterial conjunctivitis is an inflammation of the conjunctiva caused by pathogenic bacteria. Bacterial conjunctivitis is usually caused by Staphylococcus aureus, Streptococcus pneumoniae, Haemophilus sp, or, less commonly, Chlamydia trachomatis. Symptoms include redness in the white of the eye or inner eyelid, itchy eyes, blurred vision, increased sensitivity to light, and burning eyes. Treatment includes antibiotics. The Bacterial Conjunctivitis drugs in development market...
-
Product Insights
Corneal Edema - Drugs In Development, 2024
Empower your strategies with our Corneal Edema – Drugs In Development, 2024 report and make more profitable business decisions. Corneal edema is the swelling of the cornea due to the accumulation of extracellular fluid in epithelium and stroma resulting in loss of corneal transparency. The Corneal Edema drugs in development market research report provide comprehensive information on the therapeutics under development for Corneal Edema, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA),...
-
Product Insights
Corneal Ulcers - Drugs In Development, 2024
Empower your strategies with our Corneal Ulcers – Drugs In Development, 2024 report and make more profitable business decisions. A corneal ulcer is a defect in the surface epithelium of the cornea that involves the underlying stroma. It is common in contact lens wearers and presents as eye pain, blurry vision, and photophobia. This is also called as Keratitis. The Corneal Ulcers drugs in development market research report provide comprehensive information on the therapeutics under development for Corneal Ulcers, complete with...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.